Healthcare technology company Isomark LLC  announced Wednesday it received a $1.7 million Small Business Innovation Research grant from the National Institutes of Health. The grant will be used to fund its development and marketing efforts of the Canary, a breath analyzer that can detect infections from changes in a person’s metabolism.

“We’re excited by the NIH grant,” Isomark CEO Joe Kremer said in a statement. “The funding not only helps us to continue to develop and improve the Canary but also helps us with our regulatory pathway through the FDA. It is also significant to receive a ‘nod’ of validation from the experts at the NIH; we value their continued support of this project.”

The $1.7 million is a significant increase from the $150,000 the Wisconsin Alumni Research Foundation invested in the company in May.